Todd Rosengarten joined Klein Hersh in 2008 and has led the construction of KHIs bioprocess development and manufacturing practice. Originally hired as a compliment to the small molecule development team, Todd quickly realized the broad, long term potential of the biologics marketplace and shifted his focus to working with large biopharma and small biotech developing novel biologics drugs. As an example, Todd’s team has helped various start-up organizations hire Senior Executives within Technical Operations to lead products out of discovery into the clinic. Also, Todd’s practice is a key partner to global pharma clients looking to secure operational leaders to drive product launch and global manufacturing networks.
Prior to KHI, Todd attended University of Maryland, College Park, where he earned his B.A. in Government and Politics.